The Daughter’s Return
By The Economist,
The Economist
| 12. 31. 2011
A glimmer of hope in the sad tale of sex-selective abortion in India
THE march of sex-selective abortion in Asia seems relentless. Not every society adopts the practice, but those that do—and they include the two largest countries on earth—have seen it spread through every social group, unhampered by growing wealth. Indeed, middle-income couples seem more willing and better able to manipulate the sex of their children than are the poor. And they are more likely to want smaller families, increasing the premium on sons in countries where males are seen as more valuable.
As a result, richer areas have more sex selection than poorer ones and sex selection tends to rise as countries get richer. In China the sex ratio at birth is much more distorted in rich Shanghai and Guangzhou than in poor Tibet. From 2001-11, India’s GDP more than doubled and the census of 2011 found only 914 girls aged 0-6 for every 1,000 boys, worse even than the abysmal tally in 2001, when there were 927 girls per 1,000 boys. (India counts the sex ratio differently...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...